60
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

, , , , , , & show all
Pages 199-208 | Published online: 05 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eda Celikbas, Deborah Penque & Jerome Zoidakis. (2019) Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease. Expert Review of Molecular Diagnostics 19:1, pages 37-45.
Read now

Articles from other publishers (10)

Pelin Uysal. 2022. Biomarkers in Medicine. Biomarkers in Medicine 425 439 .
Elena V. Kashtanova, Yana V. Polonskaya, Evgeniia V. Striukova, Liliia V. Shcherbakova, Evgenii A. Kurtukov, Viktoriya S. Shramko, Ekaterina M. Stakhneva & Yulia I. Ragino. (2022) Blood Levels of Indicators of Lower Respiratory Tract Damage in Chronic Bronchitis in Patients with Abdominal Obesity. Diagnostics 12:2, pages 299.
Crossref
Jen-hwa Chu, Wenlan Zang, Milica Vukmirovic, Xiting Yan, Taylor Adams, Giuseppe DeIuliis, Buqu Hu, Antun Mihaljinec, Jonas C Schupp, Michael J Becich, Harry Hochheiser, Kevin F Gibson, Edward S Chen, Alison Morris, Joseph K Leader, Stephen R Wisniewski, Yingze Zhang, Frank C Sciurba, Ronald G Collman, Robert Sandhaus, Erica L Herzog, Karen C Patterson, Maor Sauler, Charlie Strange & Naftali Kaminski. (2021) Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency. Thorax 76:2, pages 134-143.
Crossref
E.V. Kashtanova, Ya.V. Polonskaya, L.V. Scherbakova, I.I. Logvinenko, E.F. Kurtukov, D.V. Denisova & Yu.I. Ragino. (2021) Abdominal obesity and the level of markers of lower respiratory tract damage in patients with chronic bronchitis. Profilakticheskaya meditsina 24:5, pages 35.
Crossref
Biaoxue Rong, Tian Fu, Congxue Rong, Wen Liu, Kai Li & Hua Liu. (2020) Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease. Scientific Reports 10:1.
Crossref
Diane Jeon, Emily G. Chang, Maggie McGing, Marlena Hartman-Filson, Mathew Sommers, Eula Lewis, John R. Balmes, Daniela Moisi, Michael M. Lederman, Kristine A. Madsen, Prescott G. Woodruff, Peter W. Hunt & Laurence Huang. (2019) Pneumoproteins are associated with pulmonary function in HIV-infected persons. PLOS ONE 14:10, pages e0223263.
Crossref
Swati Gulati, J. Michael Wells, Gisel P. Urdaneta, Kira Balestrini, Isabel Vital, Katherine Tovar, Jarrod W. Barnes, Surya P. Bhatt, Michael Campos & Stefanie Krick. (2019) Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study. International Journal of Molecular Sciences 20:9, pages 2292.
Crossref
Magno F. Formiga, Isabel Vital, Gisel Urdaneta, Brett Masters, Julio Herrera, Michael A. Campos & Lawrence P. Cahalin. (2019) Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD. The Clinical Respiratory Journal 13:4, pages 247-255.
Crossref
Maria Montes de Oca & Maria Laucho-Contreras. (2018) Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?. Medical Sciences 6:2, pages 50.
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2017) The Challenges of Precision Medicine in COPD. Molecular Diagnosis & Therapy 21:4, pages 345-355.
Crossref